Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+

Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease

(2010) Carine Karachi et al.   JOURNAL OF CLINICAL INVESTIGATION

KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis

(2010) Damien Toulorge et al.   JOURNAL OF NEUROCHEMISTRY

Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors

(2010) Uwe Maskos   JOURNAL OF NEUROCHEMISTRY

Nicotinic acetylcholine receptors and the ascending dopamine pathways

(2009) Phil D. Livingstone et al.   BIOCHEMICAL PHARMACOLOGY

Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone

(2009) Pheona M. Radcliffe et al.   JOURNAL OF NEUROCHEMISTRY

L-Type Calcium Channels Govern Calcium Signaling in Migrating Newborn Neurons in the Postnatal Olfactory Bulb

(2009) D. P. Darcy et al.   JOURNAL OF NEUROSCIENCE

Personality, Addiction, Dopamine: Insights from Parkinson's Disease

(2009) Alain Dagher et al.   NEURON

In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for Parkinson's Disease

(2008) J. Andrés Abin-Carriquiry et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels

(2008) S. Guerreiro et al.   MOLECULAR PHARMACOLOGY